Beximco Pharmaceuticals Limited

Here is the public summary page for Beximco Pharmaceuticals Limited. Please login to see the complete information for Beximco Pharmaceuticals Limited including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Beximco Pharmaceuticals Limited stacks up relative to its peers.


Darwin Score+32
TickerBXP
Latest Price0.48 GBP as of close on 15-Aug-2025
3 Month price range0.35 to 0.48 GBP
Market Capitalisation298.10Mn GBP
CountryUK
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
See More ...
Company URLhttps://www.beximcopharma.com
See Darwins Full Analysis for Beximco Pharmaceuticals Limited

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Beximco Pharmaceuticals Limited. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+22
SentimentNews and Candle Patterns. +1
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.+5
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+4

Alerts

There are 11 live alerts for Beximco Pharmaceuticals Limited.


Peer Comparison

There are 29 peers of Beximco Pharmaceuticals Limited.
Asset NameIndustry GroupPerf(20d)%Asset Score
4BASEBIO UK SOCIETAS (4BB)Biotechnology-8.6-14
Abingdon Health Plc (ABDX)Biotechnology0-25
Alliance Pharma plc (APH)Biotechnology+0.8+31
Angle PLC (AGL)Biotechnology-15.4-18
Aptamer Group PLC (APTA)Biotechnology+80.3+12
Arecor Therapeutics PLC (AREC)Biotechnology+29.6+6
Avacta Group PLC (AVCT)Biotechnology+47.7+16
BSF Enterprise Plc (BSFA)Biotechnology+1.2-16
Benchmark Holdings Plc (BMK)Biotechnology-10.7-18
BiVictriX Therapeutics PLC (BVX)Biotechnology+21.2+2
Bioventix (BVXP)Biotechnology-15.6+2
Celadon Pharmaceuticals PLC (CEL)Biotechnology0-8
Chill Brands Group PLC (CHLL)Biotechnology-2.3-21
Cizzle Biotechnology Holdings PLC (CIZ)Biotechnology-18.8-15
Destiny Pharma PLC (DEST)Biotechnology-7.7-30
Diaceutics PLC (DXRX)Biotechnology+7.0+17
Evgen Pharma PLC (EVG)Biotechnology-8.6-7
Faron Pharmaceuticals Oy (FARN)Biotechnology+2.4+12
Genflow Biosciences plc (GENF)Biotechnology-10.7-27
Genincode PLC (GENI)Biotechnology-26.3-21
Genus PLC (GNS)Biotechnology+8.3+20
Haleon PLC (HLN)Biotechnology0+4
Ondine Biomedical Inc (OBI)Biotechnology+25.0+14
Oxford BioMedica PLC (OXB)Biotechnology+33.6+41
Oxford Nanopore Technologies PLC (ONT)Biotechnology+43.5+8
Physiomics PLC (PYC)Biotechnology-10.5-9
Shield Therapeutics PLC (STX)Biotechnology+59.2+20
e-therapeutics plc (ETX)Biotechnology-28.0-4
genedrive plc (GDR)Biotechnology-39.3-8

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn